Ribosome Research Centre is a global contract research organization. RRC is the one stop solutuion for all varieties of pharmaceuticals, agrochemicals, medical devices, herbal formulations and many other such kind of products. RRC can serve different kinds of studies/testing following various pharmacopeias(e.g IP, BP, USP etc.) and/or testing guidelines (e.g OECD, ISO, EPA, EC, JMAFF, EMA, USFDA etc.) Our crew of specialists brings a complete portfolio of non-clinical regulatory toxicity testing, Phys-chem studies, bioanalysis and all other analytical services, microcbiological testing etc.
Facility has cutting edge Drug Discovery and Development Labs to support array of functions like Custom synthesis, Medicinal chemistry, cell based assays, molecular biology, Pharmacokinetics, In-Vivo Pharmacology, Regulatory toxicology, Process R & D, Formulation and Analytical development, analytical method development, biopharmaceutical development, Process & product development, nano-drug delivery system development, protein and peptides delivery system, bioavailability enhancement, novel carriers for cancer targeting etc.
The thrust areas include lead Identification and screening, cell based assays, customized animal model development for a wide range of therapeutic areas like oncology (Xenograft, Syngenic, Orthotopic, Metastasis, angiogenesis), Metabolic Disorders, Pain and inflammation, Neuro-pharmacology etc.
PRECLINICAL SERVICES & PHARMACEUTICAL QUALITY CONTROL TESTING
Safety Evalution for Pharma/Agrochemicals/Medical devices/Cosmetics/Herbal formulations to meet the requirement as per E.G. OECD/ISO/EPA/JMAFF/New drugs & Cosmetics act 1940, Pharmacopoeia, etc.
Microbiological studies as per IP, BP, USP, EP & Customer specified methods, Molecular biology studies & Other assays, Cosmetics, QSAR based safety evaluation & Biological activity evaluation, In Vitro/ In Vivo models for efficacy testing, Safety pharmacology studies, Genotoxicity testing, In Vitro alternative testing, Safety/Toxicity evaluation in rodents & Non-rodents, Medical device testing, Analytical studies.
Medical Devices
Any object intended to be used for medical purpose qualifies as a medical device. Medical devices must be demonstrated to be safe and effective with a reasonable certainty before governing governments permit the marketing of the device in their nation because there is a significant possibility for risks when utilizing a device for medical purposes. Ribosome Research Centre offers medical device testing as per GLP/ ASTM/ ISO 10993.
Cytotoxicity test, Genotoxicity test (Bacterial Reverse Mutation, Micronucleus test, Chromosomal Aberration test), Acute systemic test, ICRT (Intracutaneous Reactivity Test), Implantation test by Different routes viz. SC/IM/bone in rodents & nonrodents, Hemocompatibility testing including (Direct/indirect hemolysis, PTT, hematology, platelet count etc.), Pyrogen test as per USP/IP/BP etc., Skin Sensitization Test (GPMT & Buehler test), Single Dose Toxicity Test, Repeated dose Toxicity Test (Sub-acute/ sub-chronic/ chronic toxicity, Carcinogenicity etc.), Chemical characterization test including leachable & extractable analysis, Biological Evaluation Plan/Report & Risk Assessment Plan/Report Preparation.
Formulation Development and Related Services:-
Our team has vast experience of innovative and skillful formulation development as well as related analytical and other services. We have qualified, innovative and enthusiastic team lead by mentors having an experience of more than decade in the field of formulation development and working all varieties of services for strong support to formulation development service.
Clinical Trials:-
RRC has a highly focused team of professionals who have the knowledge and capabilities to prepare, manage and conduct all the phases of clinical trials to support diverse requirements and a robust Quality Management System guided and nurtured by our quality culture makes us a partner of choice for some of the leading pharmaceutical companies in the world.
2023 © All rights reserved by Ribosome Research Centre Pvt. Ltd.